Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Sonoma Pharmaceuticals patents

List of Sonoma Pharmaceuticals patents

List of Bruker patents

List of Nutanix patents

List of Locus Pharmaceuticals patents

List of companies in Hannover Digital Investments GmbH's investment portfolio

List of companies in Deutsche Bahn Digital Ventures (DBDV)'s investment portfolio

Patents where

Current Assignee

Name

is

Sonoma Pharmaceuticals

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 10412969 Stabilized hypochlorous acid solution and use thereof	Patent 10412969 was granted and assigned to Sonoma Pharmaceuticals on September, 2019 by the United States Patent and Trademark Office.	Sonoma Pharmaceuticals	Sonoma Pharmaceuticals		United States Patent and Trademark Office	10412969	September 17, 2019
	‌ US Patent 10342825 Solution containing hypochlorous acid and methods of using same	Patent 10342825 was granted and assigned to Sonoma Pharmaceuticals on July, 2019 by the United States Patent and Trademark Office.		Sonoma Pharmaceuticals		United States Patent and Trademark Office	10342825	July 9, 2019
	‌ US Patent 9918477 Stabilized hypochlorous acid solution and use thereof	Patent 9918477 was granted and assigned to Sonoma Pharmaceuticals on March, 2018 by the United States Patent and Trademark Office.	Sonoma Pharmaceuticals	Sonoma Pharmaceuticals		United States Patent and Trademark Office	9918477	March 20, 2018
	‌ US Patent 9642876 Method of preventing or treating sinusitis with oxidative reductive potential water solution	Patent 9642876 was granted and assigned to Sonoma Pharmaceuticals on May, 2017 by the United States Patent and Trademark Office.		Sonoma Pharmaceuticals		United States Patent and Trademark Office	9642876	May 9, 2017
	‌ US Patent 10265341 Hydrogel formulation comprising oxidative reductive potential water	Patent 10265341 was granted and assigned to Sonoma Pharmaceuticals on April, 2019 by the United States Patent and Trademark Office.		Sonoma Pharmaceuticals		United States Patent and Trademark Office	10265341	April 23, 2019
	‌ US Patent 10016455 Method of preventing or treating influenza with oxidative reductive potential water solution	Patent 10016455 was granted and assigned to Sonoma Pharmaceuticals on July, 2018 by the United States Patent and Trademark Office.	Sonoma Pharmaceuticals	Sonoma Pharmaceuticals		United States Patent and Trademark Office	10016455	July 10, 2018
	‌ US Patent 9782434 Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solution	Patent 9782434 was granted and assigned to Sonoma Pharmaceuticals on October, 2017 by the United States Patent and Trademark Office.		Sonoma Pharmaceuticals		United States Patent and Trademark Office	9782434	October 10, 2017
	‌ US Patent 10617715 Methods of treating or preventing biofilm associated infections with free available chlorine free available chlorine water			Sonoma Pharmaceuticals		United States Patent and Trademark Office	10617715	April 14, 2020

8 results

0 selected

8 results

0 selected